Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Kidney Neoplasms × olaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 87 Breast Neoplasms 68 Prostatic Neoplasms 33 Triple Negative Breast Neoplasms 32 Fallopian Tube Neoplasms 25 Neoplasms 23 Neoplasm Metastasis 21 Pancreatic Neoplasms 19 Endometrial Neoplasms 18 Small Cell Lung Carcinoma 13 Carcinoma, Ovarian Epithelial 11 Carcinoma, Non-Small-Cell Lung 10 Stomach Neoplasms 9 Sarcoma 9 Recurrence 9 Lung Neoplasms 9 Fanconi Anemia, Complementation Group D1 9 Squamous Cell Carcinoma of Head and Neck 8 Glioma 8 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Glioblastoma 7 Colorectal Neoplasms 6 Metastatic Castration-resistant Prostate Cancer 5 Lymphoma, Non-Hodgkin 5 Cholangiocarcinoma 5 Carcinoma, Renal Cell 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Solid Tumors 4 Osteosarcoma 4

Interventions

aldesleukin 42 Sunitinib 39 Cyclophosphamide 30 Nivolumab 27 Everolimus 27 pembrolizumab 26 Interferon-alpha 25 Bevacizumab 22 Sorafenib 21 Interleukin-2 20 fludarabine phosphate 19 Filgrastim 18 Radiotherapy 16 Ipilimumab 16 Peripheral Blood Stem Cell Transplantation 15 Gemcitabine 15 Axitinib 15 cabozantinib 14 Radiosurgery 11 Doxorubicin 11 Carboplatin 11 temsirolimus 10 fludarabine 10 Etoposide 9 Chemotherapy, Adjuvant 9 sargramostim 8 belzutifan 8 atezolizumab 8 Fluorouracil 8 pazopanib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03786796 2026-03-30

ORCHID

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡